Breaking News
Sort by:
Top Post
ProBioGen and ImmunOs Therapeutics Team Up to Deliver Innovative Therapy for Cancer Patients
ProBioGen, a Berlin-based specialist for developing and manufacturing biopharmaceutical active ingredients, viral vectors and vaccines, and […]
IT Veteran Vrajesh Shah Joins Zing Health as Chief Information Officer
Zing Health, a physician-led, tech-enabled Medicare Advantage plan focused on underserved communities, has named Vrajesh Shah as […]
Meletios Therapeutics Raises €3.8 Million for the Development of a New Generation of Antiviral Treatments
Meletios Therapeutics, a French biotechnology company specialized in the research and development of next-generation antiviral […]
Bico has Acquired Advanced Biomatrix, an Innovative Company Focused on 3d Applications, to, Together, Ensure a Market Leading Portfolio of Bioinks and Reagents
BICO, the leading Bio Convergence company, has acquired all outstanding shares in Advanced BioMatrix Corp. […]
Pfizer Announces New Chief Business Innovation Officer Aamir Malik
Pfizer Inc. (NYSE: PFE) today announced that Aamir Malik has joined the company as Executive […]
Genomics England Announces Appointment of New Chief Scientific Officer
Genomics England today announces the appointment of Professor Matt Brown as the organisation’s new Chief Scientific Officer […]
AllStripes Announces $50 Million Series B Financing to Advance Global Rare Disease Research
AllStripes, a healthcare technology company dedicated to unlocking treatments for people affected by rare diseases, […]
McMaster, Sartorius Stedim Biotech Team up to Advance Biomanufacturing Processes with Next-Gen Tech
Sartorius Stedim Biotech, a leading international partner of the biopharmaceutical industry, has entered into a […]
PureTech Announces the Appointment Julie Krop, M.D., as Chief Medical Officer
PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) (“PureTech” or the “Company”), a clinical-stage biotherapeutics company dedicated […]
Mirum Pharmaceuticals Appoints Biotechnology Executive William C. Fairey to its Board of Directors
Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM) today announced the appointment of industry veteran William C. Fairey […]
Aristea Appoints Justin Thacker as Chief Financial Officer
Aristea Therapeutics (Aristea), a clinical-stage immunology focused drug development company developing novel therapies to treat […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more